ERCC1 and metastatic malignant neoplasm in the lymph nodes: These observations are consistent with previous studies suggesting that high TRAP1 expression correlates with lymph node metastases [8] and, together with ERCC1, with poor OS in mCRC treated with oxaliplatin/5-fluorouracil chemotherapy [9].